Skip to main content

Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

immunotherapeutic gel SRG-514

An injectable biodegradable hydrogel, with potential immunostimulating and antineoplastic activities. Upon intraoperative injection into the site of surgical tumor resection, the immunotherapeutic gel SRG-514 releases an as of yet unidentified immunotherapeutic agent locally and may, through an as of yet unidentified mechanism of action, stimulate the cancer-suppressed immune system to eliminate any remaining cancer cells locally and systemically which may prevent cancer recurrence and metastasis after cancer surgery.

Check for active clinical trials using this agent View this agent in the NCI Thesaurus

Code name:	SRG 514 SRG-514 SRG514

immunotherapeutic gel SRG-514

Search NCI's Drug Dictionary